Mir Alireza Hoda

10PUBLICATIONS
30CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Solid tumoursMedical biotechnology diagnostics (incl. biosensors)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2026
Impact of Residual Mediastinal Nodal Disease After Neoadjuvant Chemoimmunotherapy for Non-Small Cell Lung Cancer.

|Jul 11, 2026
Current advances in extended resections for non-small cell lung cancer-a narrative review.

|May 04, 2026
MiR-21 Is a Novel Diagnostic and Prognostic Circulating Biomarker in Pleural Mesothelioma.

|Jan 28, 2026
Reactive Oxygen Species Drive Cell Migration and PD-L1 Expression via YB-1 Phosphorylation in Pleural Mesothelioma.

Muhammad Hashim, Gerald Timelthaler, Dominik Kirchhofer

|Jul 12, 2025
Management and Outcomes of Pulmonary Nodules in a Real-World Setting.

Berta Mosleh, Pavla Sarova, Helmut Prosch

|Apr 26, 2025
The Mesothelioma Systemic Inflammation Score Is Independently Associated with Overall Survival and Predicts Benefit of Multimodality Treatment in Pleural Mesothelioma.

Berta Mosleh, Katharina Sinn, Anna Cho

Pageof 2

Frequent Collaborators

6 joint publications

Clemens Aigner

5 joint publications

Berta Mosleh

4 joint publications

Balazs Dome

4 joint publications

Michael Grusch